← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 12, 2020Last known activity
Sep 30, 2025
Timeline
2010s
- Jun 1, 2019
Rivus Pharmaceuticals, Inc.— Founded
Drugs by trial phase (1 distinct, 10 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT07170189Lead sponsorPhase 1Sep 30, 2025
- NCT06486558Lead sponsorPhase 1Jul 24, 2024
- NCT06325930Lead sponsorPhase 1Mar 26, 2024
- NCT06104358Lead sponsorPhase 2Nov 17, 2023
- NCT06104358Study directorPhase 2Nov 17, 2023
- NCT05979779Lead sponsorPhase 2Sep 5, 2023
- NCT05979779Study directorPhase 2Sep 5, 2023
- NCT05284617Study directorPhase 2Oct 30, 2022
- NCT05284617Lead sponsorPhase 2Oct 30, 2022
- NCT05433506Lead sponsorPhase 1Jul 15, 2022
- NCT04874233Lead sponsorPhase 2Apr 19, 2021
- NCT04709913Lead sponsorPhase 1Jan 4, 2021
- NCT04463017Lead sponsorPhase 1Aug 12, 2020
Details
- Founded
- Charlottesville, VA, US Jun 1, 2019
- Last known activity
- Sep 30, 2025